Miraj T Patel
Examiner (ID: 3971)
Most Active Art Unit | 3655 |
Art Unit(s) | 3655 |
Total Applications | 57 |
Issued Applications | 21 |
Pending Applications | 27 |
Abandoned Applications | 9 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 15206197
[patent_doc_number] => 20190365785
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-12-05
[patent_title] => INHIBITION OF UNFOLDED PROTEIN RESPONSE FOR SUPPRESSING OR PREVENTING ALLERGIC REACTION TO FOOD
[patent_app_type] => utility
[patent_app_number] => 16/476608
[patent_app_country] => US
[patent_app_date] => 2018-02-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8923
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16476608
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/476608 | INHIBITION OF UNFOLDED PROTEIN RESPONSE FOR SUPPRESSING OR PREVENTING ALLERGIC REACTION TO FOOD | Feb 18, 2018 | Abandoned |
Array
(
[id] => 13297651
[patent_doc_number] => 20180200362
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-07-19
[patent_title] => Process for Producing an Allergen Extract
[patent_app_type] => utility
[patent_app_number] => 15/886902
[patent_app_country] => US
[patent_app_date] => 2018-02-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12466
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15886902
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/886902 | Process for Producing an Allergen Extract | Feb 1, 2018 | Abandoned |
Array
(
[id] => 17406062
[patent_doc_number] => 11246923
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-02-15
[patent_title] => Process for producing an allergen extract
[patent_app_type] => utility
[patent_app_number] => 15/886918
[patent_app_country] => US
[patent_app_date] => 2018-02-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 10
[patent_no_of_words] => 12511
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 312
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15886918
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/886918 | Process for producing an allergen extract | Feb 1, 2018 | Issued |
Array
(
[id] => 13840575
[patent_doc_number] => 20190023772
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-01-24
[patent_title] => COMPOSITIONS AND METHODS FOR REDUCING AT LEAST ONE SYMPTOM OF HUMAN ALLERGY TO CATS
[patent_app_type] => utility
[patent_app_number] => 15/874102
[patent_app_country] => US
[patent_app_date] => 2018-01-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9816
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 52
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15874102
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/874102 | Compositions and methods for reducing at least one symptom of human allergy to cats | Jan 17, 2018 | Issued |
Array
(
[id] => 15023523
[patent_doc_number] => 20190322766
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-10-24
[patent_title] => Therapeutic Anti-IgE Antibodies and Methods and Compositions Thereof
[patent_app_type] => utility
[patent_app_number] => 16/475614
[patent_app_country] => US
[patent_app_date] => 2018-01-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18197
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16475614
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/475614 | Therapeutic anti-IgE antibodies and methods and compositions thereof | Jan 4, 2018 | Issued |
Array
(
[id] => 15454519
[patent_doc_number] => 20200040084
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-02-06
[patent_title] => COMPOSITIONS AND METHODS RELATED TO ENGINEERED FC-ANTIGEN BINDING DOMAIN CONSTRUCTS
[patent_app_type] => utility
[patent_app_number] => 16/474572
[patent_app_country] => US
[patent_app_date] => 2018-01-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 86316
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16474572
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/474572 | COMPOSITIONS AND METHODS RELATED TO ENGINEERED FC-ANTIGEN BINDING DOMAIN CONSTRUCTS | Jan 4, 2018 | Abandoned |
Array
(
[id] => 15038599
[patent_doc_number] => 20190330304
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-10-31
[patent_title] => PD1-CD70 FUSION PROTEIN AND METHODS OF USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/475139
[patent_app_country] => US
[patent_app_date] => 2018-01-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 28330
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -26
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16475139
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/475139 | PD1-CD70 fusion protein and methods of use thereof | Jan 3, 2018 | Issued |
Array
(
[id] => 15831907
[patent_doc_number] => 20200131235
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-04-30
[patent_title] => RECOMBINANT DERMATOPHAGOIDES PTERONYSSINUS TYPE 2 ALLERGEN PROTEIN AND ITS PREPARATION METHOD AND APPLICATION
[patent_app_type] => utility
[patent_app_number] => 16/474217
[patent_app_country] => US
[patent_app_date] => 2017-12-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6057
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16474217
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/474217 | Recombinant | Dec 27, 2017 | Issued |
Array
(
[id] => 16267390
[patent_doc_number] => 20200268877
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-08-27
[patent_title] => ALLERGY ANTIGEN AND EPITOPE FOR SAME
[patent_app_type] => utility
[patent_app_number] => 16/608361
[patent_app_country] => US
[patent_app_date] => 2017-12-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 40587
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 399
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16608361
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/608361 | ALLERGY ANTIGEN AND EPITOPE FOR SAME | Dec 19, 2017 | Abandoned |
Array
(
[id] => 16238269
[patent_doc_number] => 20200255503
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-08-13
[patent_title] => METHOD OF TREATING AN ALLERGY WITH ALLERGEN-SPECIFIC MONOCLONAL ANTIBODIES
[patent_app_type] => utility
[patent_app_number] => 16/471213
[patent_app_country] => US
[patent_app_date] => 2017-12-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 49558
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -27
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16471213
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/471213 | Method of treating an allergy with allergen-specific monoclonal antibodies | Dec 14, 2017 | Issued |
Array
(
[id] => 15347947
[patent_doc_number] => 20200011865
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-01-09
[patent_title] => METHODS AND KITS FOR DETECTING BASOPHIL ACTIVATION
[patent_app_type] => utility
[patent_app_number] => 16/470004
[patent_app_country] => US
[patent_app_date] => 2017-12-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8698
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16470004
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/470004 | METHODS AND KITS FOR DETECTING BASOPHIL ACTIVATION | Dec 14, 2017 | Abandoned |
Array
(
[id] => 12603297
[patent_doc_number] => 20180092929
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-04-05
[patent_title] => Methods for Suppressing Allergic Reactions
[patent_app_type] => utility
[patent_app_number] => 15/836095
[patent_app_country] => US
[patent_app_date] => 2017-12-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4623
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 43
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15836095
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/836095 | Methods for suppressing allergic reactions | Dec 7, 2017 | Issued |
Array
(
[id] => 18449648
[patent_doc_number] => 20230190924
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-06-22
[patent_title] => ANTIGEN OF ALLERGY AND EPITOPE THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/617860
[patent_app_country] => US
[patent_app_date] => 2017-12-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 52343
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 110
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16617860
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/617860 | ANTIGEN OF ALLERGY AND EPITOPE THEREOF | Dec 5, 2017 | Pending |
Array
(
[id] => 18349240
[patent_doc_number] => 20230137351
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-05-04
[patent_title] => BISPECIFIC OR BIPARATOPIC ANTIGEN BINDING PROTEINS AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/349965
[patent_app_country] => US
[patent_app_date] => 2017-11-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21448
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -36
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16349965
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/349965 | BISPECIFIC OR BIPARATOPIC ANTIGEN BINDING PROTEINS AND USES THEREOF | Nov 13, 2017 | Pending |
Array
(
[id] => 12675931
[patent_doc_number] => 20180117143
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-05-03
[patent_title] => PHARMACEUTICAL COMPOSITION FOR TREATMENT OF ALLERGIC REACTIONS
[patent_app_type] => utility
[patent_app_number] => 15/804532
[patent_app_country] => US
[patent_app_date] => 2017-11-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20435
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 64
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15804532
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/804532 | PHARMACEUTICAL COMPOSITION FOR TREATMENT OF ALLERGIC REACTIONS | Nov 5, 2017 | Abandoned |
Array
(
[id] => 15915401
[patent_doc_number] => 10654929
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-05-19
[patent_title] => Antibodies to PD-1 and uses thereof
[patent_app_type] => utility
[patent_app_number] => 15/800346
[patent_app_country] => US
[patent_app_date] => 2017-11-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 45387
[patent_no_of_claims] => 36
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 90
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15800346
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/800346 | Antibodies to PD-1 and uses thereof | Oct 31, 2017 | Issued |
Array
(
[id] => 14993843
[patent_doc_number] => 20190315879
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-10-17
[patent_title] => ADAPTER CHIMERIC ANTIGEN RECEPTOR EXPRESSING CELLS FOR TARGETING OF MULTIPLE ANTIGENS
[patent_app_type] => utility
[patent_app_number] => 16/343162
[patent_app_country] => US
[patent_app_date] => 2017-10-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17171
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 116
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16343162
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/343162 | ADAPTER CHIMERIC ANTIGEN RECEPTOR EXPRESSING CELLS FOR TARGETING OF MULTIPLE ANTIGENS | Oct 26, 2017 | Abandoned |
Array
(
[id] => 14808385
[patent_doc_number] => 20190270802
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-09-05
[patent_title] => TREATING CANCER WITH A COMBINATION OF A PD-1 ANTAGONIST AND AN IL-27 ANTAGONIST
[patent_app_type] => utility
[patent_app_number] => 16/342283
[patent_app_country] => US
[patent_app_date] => 2017-10-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11335
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16342283
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/342283 | TREATING CANCER WITH A COMBINATION OF A PD-1 ANTAGONIST AND AN IL-27 ANTAGONIST | Oct 18, 2017 | Abandoned |
Array
(
[id] => 16175562
[patent_doc_number] => 20200222530
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-07-16
[patent_title] => PREVENTION OF ALLERGY
[patent_app_type] => utility
[patent_app_number] => 16/338672
[patent_app_country] => US
[patent_app_date] => 2017-10-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4160
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16338672
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/338672 | PREVENTION OF ALLERGY | Oct 4, 2017 | Abandoned |
Array
(
[id] => 14715561
[patent_doc_number] => 20190248844
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-08-15
[patent_title] => POLYPEPTIDE CONSTRUCT COMPRISING FRAGMENTS OF ALLERGENS
[patent_app_type] => utility
[patent_app_number] => 16/335022
[patent_app_country] => US
[patent_app_date] => 2017-09-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12041
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -31
[patent_words_short_claim] => 93
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16335022
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/335022 | Polypeptide construct comprising fragments of allergens | Sep 19, 2017 | Issued |